According to Zhitong Financial App News, Qiming Medical-B (02500) announced that the company received a letter from the Stock Exchange on February 9, 2024. According to this, the Stock Exchange issued additional guidance on resuming trading to the company after the death of Mr. Lau Yun-yi: re-complying with the requirements of section 3.10 (1), section 3.10A, section 3.21 and section 3.27A of the listing rules relating to the composition and chairman of the board committee (if applicable). Trading of the company's shares continues to be suspended.
启明医疗-B(02500)接获联交所额外复牌指引 继续停牌
Kai Ming Medical-B (02500) received additional guidance from the Exchange to resume trading and continued to be suspended
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.